• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

    5/9/25 1:10:54 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $GRDN alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    GUARDIAN PHARMACY SERVICES, INC.

    (Name of Issuer)


    Class A Common Stock, par value $0.001 per share

    (Title of Class of Securities)


    40145W101

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    40145W101


    1Names of Reporting Persons

    Franklin Resources, Inc.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    738,577.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    738,577.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    738,577.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    8.0 %
    12Type of Reporting Person (See Instructions)

    HC, CO


    SCHEDULE 13G

    CUSIP No.
    40145W101


    1Names of Reporting Persons

    Charles B. Johnson
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    0.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0 %
    12Type of Reporting Person (See Instructions)

    HC, IN


    SCHEDULE 13G

    CUSIP No.
    40145W101


    1Names of Reporting Persons

    Rupert H. Johnson, Jr.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    0.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0 %
    12Type of Reporting Person (See Instructions)

    HC, IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    GUARDIAN PHARMACY SERVICES, INC.
    (b)Address of issuer's principal executive offices:

    300 Galleria Parkway SE Suite 800, Atlanta, GA 30339
    Item 2. 
    (a)Name of person filing:

    (i): Franklin Resources, Inc. (ii): Charles B. Johnson (iii): Rupert H. Johnson, Jr.
    (b)Address or principal business office or, if none, residence:

    (i), (ii), (iii): One Franklin Parkway San Mateo, CA 94403-1906
    (c)Citizenship:

    (i): Delaware (ii) and (iii): USA
    (d)Title of class of securities:

    Class A Common Stock, par value $0.001 per share
    (e)CUSIP No.:

    40145W101
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    738,577
    (b)Percent of class:

    8.0%
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    Franklin Resources, Inc.: 0 Charles B. Johnson: 0 Rupert H. Johnson, Jr.: 0 Putnam Investment Management, LLC: 427,605 The Putnam Advisory Company, LLC: 85,124 Templeton Investment Counsel, LLC: 225,848

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    Franklin Resources, Inc.: 0 Charles B. Johnson: 0 Rupert H. Johnson, Jr.: 0 Putnam Investment Management, LLC: 427,605 The Putnam Advisory Company, LLC: 85,124 Templeton Investment Counsel, LLC: 225,848

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The clients of the Investment Management Subsidiaries, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, the securities reported herein.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See Attached Exhibit C
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Franklin Resources, Inc.
     
    Signature:/s/Thomas C. Mandia
    Name/Title:Thomas C. Mandia, Assistant Secretary of Franklin Resources, Inc.
    Date:05/05/2025
     
    Charles B. Johnson
     
    Signature:/s/Thomas C. Mandia
    Name/Title:Attorney in Fact for Charles B. Johnson pursuant to Power of Attorney
    Date:05/05/2025
     
    Rupert H. Johnson, Jr.
     
    Signature:/s/Thomas C. Mandia
    Name/Title:Attorney in Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney
    Date:05/05/2025

    Comments accompanying signature:  LIMITED POWERS OF ATTORNEY FOR SECTION 13 AND 16 REPORTING OBLIGATIONS (incorporated by reference to Schedule 13G filed on October 31, 2024)
    Exhibit Information

    Exhibit A: Joint Filing Agreement Exhibit B: Item 4 Ownership Exhibit C: Item 7 Identification and Classification of Subsidiaries Exhibit A: JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other of the attached statement on Schedule 13G and to all amendments to such statement and that such statement and all amendments to such statement are made on behalf of each of them. IN WITNESS WHEREOF, the undersigned have executed this agreement on the date of the signing of this filing. Franklin Resources, Inc. Charles B. Johnson Rupert H. Johnson, Jr. By: /s/THOMAS C. MANDIA Assistant Secretary of Franklin Resources, Inc. Attorney-in-Fact for Charles B. Johnson pursuant to Power of Attorney Attorney-in-Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney Exhibit B: Item 4 Ownership The securities reported herein are beneficially owned by one or more open or closed end investment companies or other managed accounts that are investment management clients of investment managers that are direct and indirect subsidiaries (each, an "Investment Management Subsidiary" and, collectively, the "Investment Management Subsidiaries") of Franklin Resources Inc. ("FRI"), including the Investment Management Subsidiaries listed in this Item 4. When an investment management contract (including a sub advisory agreement) delegates to an Investment Management Subsidiary investment discretion or voting power over the securities held in the investment advisory accounts that are subject to that agreement, FRI treats the Investment Management Subsidiary as having sole investment discretion or voting authority, as the case may be, unless the agreement specifies otherwise. Accordingly, each Investment Management Subsidiary reports on Schedule 13G that it has sole investment discretion and voting authority over the securities covered by any such investment management agreement, unless otherwise noted in this Item 4. As a result, for purposes of Rule 13d-3 under the Act, the Investment Management Subsidiaries listed in this Item 4 may be deemed to be the beneficial owners of the securities reported in this Schedule 13G. Beneficial ownership by Investment Management Subsidiaries and other FRI affiliates is being reported in conformity with the guidelines articulated by the SEC staff in Release No. 34-39538 (January 12, 1998) (the "1998 Release") relating to organizations, such as FRI, where related entities exercise voting and investment powers over the securities being reported independently from each other. The voting and investment powers held by each of FRI's affiliates whose ownership of securities is disaggregated from that of FRI in accordance with the 1998 Release ("FRI Disaggregated Affiliates") are exercised independently from FRI and from all other Investment Management Subsidiaries (FRI, its affiliates and the Investment Management Subsidiaries other than FRI Disaggregated Affiliates are collectively, "FRI Aggregated Affiliates"). Furthermore, internal policies and procedures of, on the one hand, FRI Disaggregated Affiliates, and, on the other hand, FRI establish informational barriers that prevent the flow among, on the one hand, FRI Disaggregated Affiliates (including preventing the flow between such entities), and, on the other hand, the FRI Aggregated Affiliates of information that relates to the voting and investment powers over the securities owned by their respective investment management clients. Consequently, FRI Disaggregated Affiliates report the securities over which they hold investment and voting power separately from the FRI Aggregated Affiliates for purposes of Section 13 of the Act. Charles B. Johnson and Rupert H. Johnson, Jr. (the "Principal Shareholders") may each own in excess of 10% of the outstanding common stock of FRI and are the principal stockholders of FRI (see FRI's Proxy Statement-Stock Ownership of Certain Beneficial Owners). FRI and the Principal Shareholders may be deemed to be, for purposes of Rule 13d-3 under the Act, the beneficial owners of securities held by persons and entities for whom or for which FRI subsidiaries provide investment management services. The number of shares that may be deemed to be beneficially owned and the percentage of the class of which such shares are a part are reported in Items 9 and 11 of the cover page for FRI. FRI, the Principal Shareholders and each of the Investment Management Subsidiaries disclaim any pecuniary interest in any of such securities. In addition, the filing of this Schedule 13G on behalf of the Principal Shareholders, FRI and the FRI Aggregated Affiliates, as applicable, should not be construed as an admission that any of them is, and each of them disclaims that it is, the beneficial owner, as defined in Rule 13d-3, of any of the securities reported in this Schedule 13G. FRI, the Principal Shareholders, and each of the Investment Management Subsidiaries believe that they are not a "group" within the meaning of Rule 13d-5 under the Act and that they are not otherwise required to attribute to each other the beneficial ownership of the securities held by any of them or by any persons or entities for whom or for which the Investment Management Subsidiaries provide investment management services. EXHIBIT C: Item 7 Identification and Classification of Subsidiaries Putnam Investment Management, LLC: Item 3 Classification: 3(e) The Putnam Advisory Company, LLC: Item 3 Classification: 3(e) Templeton Investment Counsel, LLC: Item 3 Classification: 3(e)

    Get the next $GRDN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GRDN

    DatePrice TargetRatingAnalyst
    10/21/2024$21.00Outperform
    Raymond James
    10/21/2024$22.00Buy
    Truist
    More analyst ratings

    $GRDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

      SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      12/6/24 12:05:09 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

      SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      11/14/24 4:30:13 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

      SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      11/14/24 1:01:24 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Financials

    Live finance-specific insights

    See more
    • Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its first quarter 2025 results on Monday, May 12, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "96083." A replay will be available shortly after the call's completion and remain available for approximately 60 days

      4/30/25 4:12:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its third quarter 2024 results on Tuesday, November 12, 2024, after market close and host a conference call to review the results at 4:30pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (800) 245-3047 for U.S. participants, or (203) 518-9765 for international participants, and referencing conference ID "Guardian." A replay will be available shortly after the call's completion and remain available for approximately 60

      10/30/24 8:00:00 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cosler Steven D bought $148,540 worth of shares (7,000 units at $21.22), increasing direct ownership by 65% to 17,713 units (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      11/20/24 4:05:12 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Salentine Thomas J Jr bought $499,996 worth of shares (35,714 units at $14.00) (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      10/1/24 5:48:50 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Patchett Mary Sue bought $49,994 worth of shares (3,571 units at $14.00) and was granted 3,571 shares (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      10/1/24 5:46:36 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

      Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

      5/8/25 4:05:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its first quarter 2025 results on Monday, May 12, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "96083." A replay will be available shortly after the call's completion and remain available for approximately 60 days

      4/30/25 4:12:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services Opens New Columbus, Ohio, Location, Strengthening Long-Term Care Presence in Ohio, Kentucky and West Virginia

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, and Mullaney's Pharmacy, a Guardian Pharmacy member based in Cincinnati, today announced the opening of a new pharmacy in Columbus, Ohio. Operating as Guardian Pharmacy of Ohio, the new location – together with the Cincinnati pharmacy – will strengthen Guardian's presence in the region and allow it to provide even better service to residents in assisted living, skilled nursing and behavioral health communities as well as individuals with intellectual and developmental disabilities across Ohio, northern and central Kentucky, and western West Virginia

      4/14/25 10:03:00 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Raymond James initiated coverage on Guardian Pharmacy Services with a new price target

      Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00

      10/21/24 8:25:47 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Truist initiated coverage on Guardian Pharmacy Services with a new price target

      Truist initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $22.00

      10/21/24 7:42:42 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Leadership Updates

    Live Leadership Updates

    See more
    • Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

      Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

      5/8/25 4:05:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy

      Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent

      12/17/24 9:00:00 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

      SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      5/9/25 1:33:37 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

      SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      5/9/25 1:10:54 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

      SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      4/22/25 1:39:40 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Bindley William E converted options into 6,100,176 shares (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      4/1/25 4:59:51 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Officer Morris David K converted options into 641,869 shares, increasing direct ownership by 6,181% to 652,254 units (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      4/1/25 4:15:15 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Officer Burke Fred converted options into 1,298,826 shares (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      4/1/25 4:15:06 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples